Home - Products - Cell Cycle/DNA Damage - CDK - CDK-IN-10

CDK-IN-10

CAS No. 660822-84-4

CDK-IN-10( —— )

Catalog No. M35483 CAS No. 660822-84-4

CDK-IN-10 is a cell cycle protein-dependent kinase (CDK) inhibitor with potential anticancer activity for cancer research.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	193	In Stock
10MG	276	In Stock
25MG	430	In Stock
50MG	581	In Stock
100MG	768	In Stock
200MG	1032	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

CDK-IN-10
Note

Research use only, not for human use.
Brief Description

CDK-IN-10 is a cell cycle protein-dependent kinase (CDK) inhibitor with potential anticancer activity for cancer research.
Description

CDK-IN-10 (example 54) is a cyclin dependent kinase (CDK) inhibitor that can be used in cancer research.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Cell Cycle/DNA Damage
Target

CDK
Recptor

CDK
Research Area

——
Indication

——

Chemical Information

CAS Number

660822-84-4
Formula Weight

322.36
Molecular Formula

C18H18N4O2
Purity

>98% (HPLC)
Solubility

——
SMILES

C(NC1=CC=C(C=C1)N2CCOCC2)(=O)C=3C=4C(NN3)=CC=CC4
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Valerio Berdini, et al. 1h-indazole-3-carboxamide compounds as cyclin dependent kinases (cdk) inhibitors. WO2004014864

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Riviciclib

A novel potent CDK inhibitor with IC50 of 79 nM, 63 nM and 20 nM for Cdk4/cyclin D1, Cdk1/cyclin B and Cdk9/cyclin T1, respectively.
FIT-039

FIT-039 is a potent, selective CDK9 inhibitor with IC50 of 5.8 uM for CKD9/cyclin T1, suppresses the replication of HSV-1 (IC50=0.69 uM)
CYC065

CYC065 is a derivative of seliciclib and second generation CDK inhibitor that is mainly active on CDK2/5/9.

Sign In Join Free